Skip to content
Open access

Immuno-informatics strategy for designing and development of a multi-epitope chimeric vaccine for livestock against Taenia infections

Aug 2026 · Discover Life · Vol 56 · 0 citations · 108 references

TL;DR

The computationally designed vaccine meets all essential criteria and has shown immense potential to be an effective vaccine through in silico analysis, however, additional In-vitro and In-vivo validations are imperative.

Abstract

Livestock production is a major contributor to food security and livelihoods worldwide. Among the parasitic diseases affecting livestock, Taenia solium infection remains a significant veterinary and public health concern, causing substantial economic losses. Therefore, effective and affordable vaccine development is required for disease prevention and improved livestock health. A multi-epitopic chimeric vaccine for livestock against Taenia spp. was computationally designed using subtractive proteomics and immuno-informatics. Antigenic proteins were selected based on antigenicity, allergenicity, and physicochemical profiling. HTL, CTL, and B-cell epitopes were predicted and assembled into a chimeric structure along with a suitable adjuvant. Structure modeling and physical characteristics, such as docking tendency with TLRs, along with the immune stimulatory response, were analysed. Molecular dynamics simulations for the TLR4-Vaccine complexes were also done for 100 ns. Immune simulation and codon optimisation predicted immunogenicity and expression potential in E. coli. 11 epitopes were identified from 3 antigenic homologous proteins. A multiepitope chimeric vaccine was designed by adding β-defensin adjuvant to mount a robust immune response. The proposed vaccine construct had 272 Amino acid residues and a molecular weight of 28.94 kDa. Upon binding with TLR4 receptors, it establishes a stable conformation, and molecular dynamics simulations also demonstrated a dynamic interplay. A multi-epitope vaccine capable of disrupting the life cycle of Taenia species across all known hosts was designed. The computationally designed vaccine meets all essential criteria and has shown immense potential to be an effective vaccine through in silico analysis. However, additional In-vitro and In-vivo validations are imperative.

Read PDF

Similar papers

Open access Aug 2026

In Silico design and evaluation of a multi-epitope vaccine candidate against Toxoplasma gondii for humans

The rationally designed multi-epitope vaccine demonstrates robust theoretical potential to elicit comprehensive, long-lasting immunity in humans, although its safety and effectiveness require additional experimental validation.

Chenchen Yi, Yu Shen, Ye Luo et al. · 0 citations
Open access Jul 2026

An integrated subtractive genomics and immunoinformatics approach for designing a universal multi-epitope vaccine against Brucella spp.

Vc7 has been identified as a structurally stable and highly immunogenic construct, suggesting its potential as a universal multi-epitope vaccine candidate for the prevention of brucellosis.

Rhitam Biswas, Swapno Surabhi Sinha, Aditi Roy et al. · 0 citations
Open access Jul 2026

Integrative immunoinformatics and structural modeling for the rational design of a multi-epitope vaccine candidate against human cytomegalovirus

The results highlight the potential of the proposed multi-epitope construct as a promising vaccine candidate against HCMV, however, experimental validation is essential to confirm its immunogenicity, safety, and translational applicability.

O. P. Emmanuel, M. N. Y. Sandrine, Bilanda Danielle Claude et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.